23 July 2023>: Clinical Research
Assessing the Impact of the Zero Mother Mortality Preeclampsia Program on Maternal Mortality Rates at a Single Center in Bandung, West Java (2015–2022): A Retrospective Study
Adhi Pribadi 1ABCDEFG* , Dini Hidayat 2ABCD , R.M. Sonny Sasotya 3ABCD , Muhammad Alamsyah Aziz 1ABCD , Windi Nurdiawan 2ABCD , Akhmad Yogi Pramatirta 1ABCD , Amillia Siddiq 1ABCD , Johanes Cornelius Mose 1BCD , Yudi Mulyana Hidayat 3ABCDE , Annisa Dewi Nugrahani 1EF , Dhanny Primantara Johari Santoso 1EF , Wiryawan Permadi 4ABCDDOI: 10.12659/MSM.941097
Med Sci Monit 2023; 29:e941097
Table 1 Total maternal mortality, diagnosis characteristic, and related complications.
Year of | MMN | MMHN//% | MMHN/% | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Total | GH | PE | CH | CH-S | EC | |||||
2015 | 20 | 11/55 | 1 | 3 | 1 | 1 | 5 | |||
2016 | 16 | 7/43.7 | 4 | 1 | 2 | |||||
2017 | 25 | 11/44 | 5 | 3 | 3 | |||||
2018 | 21 | 13/61.0 | 2 | 5 | 6 | |||||
2019 | 36 | 13/36.1 | 2 | 1 | 6 | 4 | ||||
2020 | 27 | 5/18.5 | 2 | 3 | ||||||
2021 | 8 | 1/12.5 | 1 | |||||||
2022 | 19 | 2/10.5 | 1 | 1 | ||||||
Total | 172 | 63/36.6 | 63/100 | 1/1.6 | 19/30.2 | 2/3.2 | 16/25.4 | 25/39.6 | ||
2015 | 20 | 11/55 | 5 | 6 | 2 | 2 | ||||
2016 | 16 | 7/43.7 | 3 | 5 | 3 | 1 | ||||
2017 | 25 | 11/44 | 3 | 5 | 1 | 1 | ||||
2018 | 21 | 13/61.0 | 2 | 7 | 2 | 2 | 1 | |||
2019 | 36 | 13/36.1 | 3 | 7 | 2 | 1 | 1 | |||
2020 | 27 | 5/18.5 | 3 | 4 | 1 | 1 | 2 | |||
2021 | 8 | 1/12.5 | ||||||||
2022 | 19 | 2/10.5 | 1 | 1 | 1 | 1 | ||||
Total | 172 | 63/36.6 | 77/100 | 17/22 | 35/45.5 | 12/15.6 | 7/9.1 | 1/1.3 | 3/3.9 | 2/2.6 |
MM – maternal mortality (total); MMH – maternal mortality due to hypertension; GH – gestational hypertension; PE – preeclampsia; CH – chronic hypertension; CH-S – chronic hypertension superimposed; EC – eclampsia; HELLP – hemolytics elevated liver enzyme low platelets counts; HC/LE – heart complications/lung edema; AKI – acute kidney injury. Related complications that arise in a patient could occur multiple times. |